CCND1 and cancer: Cyclin D1 and cyclin D3 are dysregulated in a variety of human cancers, and the inhibition of these proteins represents a highly selective anticancer strategy that specifically targets cancer cells without significantly affecting normal tissues 15, 18, 31, 32, 33.